# Trial of Low-intensity Anticoagulation to Reduce GI or Other Bleeding Complications With Equivalent Therapeutic Efficacy in HeartMate 3 LVAD Patients

> **NCT07081035** · PHASE4 · NOT_YET_RECRUITING · sponsor: **Asan Medical Center** · enrollment: 94 (estimated)

## Conditions studied

- Advanced Heart Failure
- Left Ventricular Assist Devices
- Anticoagulation Treatment
- Bleeding Complications
- Thrombotic Complications

## Interventions

- **DRUG:** Warfarin (low-intensity anticoagulation)
- **DRUG:** Warfarin (standard anticoagulation)

## Key facts

- **NCT ID:** NCT07081035
- **Lead sponsor:** Asan Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-10
- **Primary completion:** 2028-10
- **Final completion:** 2029-01
- **Target enrollment:** 94 (ESTIMATED)
- **Last updated:** 2025-07-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07081035

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07081035, "Trial of Low-intensity Anticoagulation to Reduce GI or Other Bleeding Complications With Equivalent Therapeutic Efficacy in HeartMate 3 LVAD Patients". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT07081035. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*